
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Journalist reported killed in the Gaza Strip02.12.2025 - 2
6 Famous Cell phone Brands All over The Planet05.06.2024 - 3
Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says28.11.2025 - 4
Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World31.12.2025 - 5
Vote in favor of your #1 Kind of Cap06.06.2024
Longtime United Launch Alliance CEO Tory Bruno resigns from space company. 'Finished the mission I came to do.'
4 Family SUVs: Joining Solace and Style
Putting pig organs in people is OK in the US, but growing human organs in pigs is not – why is that?
Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game
Online business Stages for Little Retailers
Pentagon advances Golden Dome missile defense with new Space Force contracts
Will your baby get a hep B vaccine? What RFK panel's ruling means.
Former 'Bachelorette' welcomes 1st baby via emergency c-section
Misinterpretations and Mistakes Portrayed by Hollywood in the General set of laws













